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Letters
RESEARCH LETTER
Association of Genetic Risk for Schizophrenia
and Bipolar Disorder With Infant Neuromotor
Development
Schizophrenia and bipolar disorder (BD) are heritable disor-
ders with similarities in clinical symptoms and typical onset
after puberty.1 While research shows that impaired motor co-
ordination can have an association with schizophrenia,2 there
are limited data on childhood development preceding BD.
Murray et al1 proposed a developmental model for similari-
ties and dissimilarities between schizophrenia and BD, but it
remains unknown if dissimilarities exist in early infancy and
if they covary with genetic liability for these disorders. Using
polygenic risk scores (PRSs), we explored whether genetic risk
for schizophrenia and genetic risk for BD are associated with
neuromotor development in infancy.
Methods | The present study was embedded in the Generation
R Study (n = 7893), a population-based study from fetal life for-
ward in Rotterdam, the Netherlands. From this cohort, we iden-
tified a pediatric sample of European ancestry (defined by ge-
netic principal components [based on population-specific
variations in allele distribution]) by genotype data (n = 2830).3
Of these, 1174 infants (41.5%) underwent neuromotor exami-
nation at 2.9 months (range, 2-5 months). Polygenic risk scores
were calculated using an R script (PRSice version 1.25) for
schizophrenia and BD using genome-wide association study






Supine Resting posture Legs flat on the
surface
Semiflexed legs; slight
abduction at the hips
Legs stretched
Adductor angle >140° >80° to <140° <80°
Popliteal angle 130° to 180° 90° to 130° <90°
Ankle angle <20° >20° to <90° >90°
Head preference Yes No
Opening and closing
hands




Grasps with one hand Decreased Yes Absent
Hyperextension Sometimes No Yes
Dyskinesia Sometimes No Yes








Head lag Active lift of head Exaggerated
Horizontal Ventral tone Low tone Normal tone Back and limbs stretched
Vertical Head Low tone Normal tone High tone
Shoulders Low tone Normal tone High tone
Trunk Low tone Normal tone High tone
Legs Low tone Normal tone High tone
Prone Pulls arms up No Yes
Turns head No Yes
Lifts head No Yes Overstretched
Sitting Needs support No Yes
Head control No Yes
Shoulder retraction Yes No
Shape of the back Straight Round Scoliosis
(continued)
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(GWAS) summary statistics and were standardized to a mean
(SD) of 0 (1) for interpretability. Additive PRS were calculated
for each individual by multiplying the allele count by the al-
lele log of the odds ratio (OR). Single-nucleotide polymor-
phisms were clumped prior to calculation of the score.4 Full
details have been described elsewhere.4 The Erasmus Medi-
cal Center Medical Ethics Committee approved the study. Writ-
ten informed consent was obtained from parents of infants.
Research nurses assessed neuromotor development dur-
ing a home visit using an adapted version of the Touwen Neu-
rodevelopmental Examination (Table 1).5 The lowest and
middle tertiles were classified as optimal. Nonoptimal neuro-
motor development was defined as an age-corrected score in
the highest tertile. We performed logistic regression adjusted
for sex and population structure by including the first 4 ge-
netic principal components. Two-sided P < .05 was the thresh-
old of statistical significance.
Results | Among the 1174 infants examined, 596 (50.8%) were
male and 578 (49.2%) were female. In this cohort, a higher PRS
for schizophrenia was associated with nonoptimal overall in-
fant neuromotor development at age 2 to 5 months (GWAS
P value threshold <.05) (OR, 1.15; 95% CI, 1.01-1.30; P = .03).
The results remained essentially unchanged across the range
from P < .05 to P < .0005). A PRS for BD was not consistently
associated with nonoptimal overall infant neuromotor devel-
opment (OR, 0.95; 95% CI, 0.84-1.08; P = .44) (Table 2).
Discussion | This report indicates that the PRSs for schizophrenia
are associated with nonoptimal overall infant neuromotor de-
velopment, whereas no consistent associations were observed
forBDPRSs.Similarly,Burtonetal6 foundanassociationbetween
motor development at 7 years with familial risk for schizophre-
nia, but not with familial risk for BD. To date, the earliest age for
manifestation of genetic predisposition for schizophrenia was









Babinski reflex Exaggerated Yes Spontaneous
Prone Bauer reflex Exaggerated Yes / weak
Vertical Stepping movements Yes No Exaggerated
Moro intensity Exaggerated Yes / weak
Moro opening hands No Yes
Other
Supine Strabismus Sometimes No Yes




Hearing Moderate Yes No
Sweating Yes No
Startles Sometimes No Yes
aThis table has been adapted from
information in van Batenburg-Eddes,
et al.5
Table 2. Nonoptimal Neuromotor Development in 1174 Infants Aged 2 to 5 Months, Corrected for Agea
Threshold OR (95% CI) P Value SNP,b No.
Schizophrenia
P < .0005 1.14 (1.00-1.29) .05 2965
P < .001 1.14 (1.00-1.29) .04 4148
P < .005 1.14 (1.01-1.30) .04 9547
P < .01 1.14 (1.01-1.30) .03 13 916
P < .05 1.15 (1.01-1.30) .03 34 947
P < .10 1.12 (0.99-1.27) .08 52 256
P < .50 1.12 (0.99-1.26) .08 126 674
Bipolar Disorder
P < .0005 0.87 (0.77-0.98) .02 525
P < .001 0.92 (0.82-1.04) .20 915
P < .005 0.99 (0.88-1.11) .85 2946
P < .01 0.95 (0.84-1.07) .40 4992
P < .05 0.95 (0.84-1.08) .44 16 461
P < .10 0.91 (0.81-1.03) .14 27 366
P < .50 0.92 (0.81-1.03) .15 79 569
Abbreviations: OR, odds ratio;
SNP, single-nucleotide
polymorphism.
a The models are adjusted for sex and




b SNPs were clumped prior to
calculation of score.
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reported by Jansen et al4 in 3-year-old children. Research sug-
gests that impaired neuromotor development precedes schizo-
phrenia onset, although most children with impaired neuromo-
tor functioning do not develop schizophrenia.2 In contrast,
children who later met criteria for BD exhibited a higher level of
motor performance during childhood than controls.1 Our results
highlight that the genetic predisposition for schizophrenia
covaries with motor deficits observable during infancy in a
community-based sample. Given that the prevalence of schizo-
phrenia is low, these early features represent indices of liability
rather than precursors of the disorder.
This study has certain limitations. Genetic pleiotropy or
early environmental factors could also explain the association.1
Selective nonresponse to neuromotor assessment could bias
the analysis. The power of the BD GWAS might have been in-
sufficient to detect associations between BD PRS and neuro-
motor development. Despite limitations, this study has sev-
eral strengths, including an objective and prospectively
assessed measure of neuromotor development in a large ho-
mogenous sample of infants.
To our knowledge, this is the first evidence that genetic
liability for schizophrenia may covary with altered neuromo-
tor development in infancy. Future research will show whether
early neuromotor development can support early screening of
susceptible groups possibly defined by genetic risk.
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Assessment of Symptom Network Density
as a Prognostic Marker of Treatment Response
in Adolescent Depression
One in 4 adolescents with depression does not respond favor-
ably to treatment.1 Prognostic markers to identify this nonre-
sponder group are lacking and urgently needed.2 It has been
suggested that the network structure of depressive symp-
toms (ie, group-level covariance or connectivity between symp-
toms) may be informative in this regard.3 Intuitively, one may
expect that more densely connected networks would be more
inclined to result in negative spirals (eg, sleeplessness causes
an individual to be too tired to go out, which leads to a lack of
friends, resulting in sadness) and therefore more liable to non-
response. An influential naturalistic study by van Borkulo et
al published in JAMA Psychiatry3 reported that adult patients
with depression who continue to experience problems in sub-
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